US Patent Issued to The Regents of the University of California, UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF THE VETERANS AFFAIRS on Sept. 15 for "Combination immunotherapy" (California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,466, issued on Sept. 15, was assigned to The Regents of the University of California (Oakland, Calif.) and UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF THE VETERANS AFFAIRS (Washington).

"Combination immunotherapy" was invented by Steven M. Dubinett (Los Angeles), Sherven Sharma (Culver City, Calif.) and Jay M. Lee (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is based on the disclosure provided herein that secondary lymphoid organ chemokine (SLC) inhibits the growth of syngeneic tumors in vivo. Thus, the invention provides a method of treating cancer in a mammal subject by administering a therapeutically ef...